Evidence map›Paper›PMID 34452150›Full record

ArticlePharmaceutics2021

Cellulose Nanofiber-Based Hydrogels Embedding 5-FU Promote Pyroptosis Activation in Breast Cancer Cells and Support Human Adipose-Derived Stem Cell Proliferation, Opening New Perspectives for Breast Tissue Engineering.

Liliana-Roxana Balahura, Sorina Dinescu, Mihaela Balaș, Alexandra Cernencu, Adriana Lungu, George Mihail Vlăsceanu, Horia Iovu, Marieta Costache

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Advanced Hydrogels in Breast Cancer Therapy.Gels (Basel, Switzerland) · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liliana-Roxana BalahuraDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0003-1338-5280
Sorina DinescuDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0001-7196-1712
Mihaela BalașDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0001-9522-0118
Alexandra CernencuAdvanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.ORCID 0000-0003-4356-2612
Adriana LunguAdvanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.ORCID 0000-0003-3532-7786
George Mihail VlăsceanuAdvanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.ORCID 0000-0002-9876-6180
Horia IovuAdvanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.
Marieta CostacheDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0002-8103-3693
Universitatea Națională de Știință și Tehnologie Politehnica București · ROUniversity of Bucharest · RO

Funding

Romanian Ministry of Research and Innovation, CCCDI-UEFISCDI PN-III-P1-1.2-PCCDI-2017-0782/REGMED
6 · The paper itself

Abstract

The structure and biocompatibility analysis of a hydrogel based on cellulose nanofibers (CNFs) combined with alginate/pectin (A.CNF or P.CNF) and enriched with 1% or 5% 5-FU revealed more favorable properties for the cellular component when pectin was dispersed within CNFs. 5-Fluorouracil (5-FU) is an antimetabolite fluoropyrimidine used as antineoplastic drug for the treatment of multiple solid tumors. 5-FU activity leads to caspase-1 activation, secretion and maturation of interleukins (IL)-1, IL-18 and reactive oxygen species (ROS) generation. Furthermore, the effects of embedding 5-FU in P.CNF were explored in order to suppress breast tumor cell growth and induce inflammasome complex activation together with extra- and intracellular ROS generation. Exposure of tumor cells to P.CNF/5-FU resulted in a strong cytotoxic effect, an increased level of caspase-1 released in the culture media and ROS production-the latter directly proportional to the concentration of anti-tumor agent embedded in the scaffolds. Simultaneously, 5-FU determined the increase of p53 and caspase-1 expressions, both at gene and protein levels. In conclusion, P.CNF/5-FU scaffolds proved to be efficient against breast tumor cells growth due to pyroptosis induction. Furthermore, biocompatibility and the potential to support human adipose-derived stem cell growth were demonstrated, suggesting that these 3D systems could be used in soft tissue reconstruction post-mastectomy.

Indexed as

3D scaffolds5-fluorouracilbreast cancercaspase-1cellulose nanofibersinflammasomep53pectintissue regeneration

Identifiers

PMID34452150
PMCPMC8400202
OpenAlexW3189449884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.